| Financial Year |
March 31 2023 |
| Monetary Funds |
12,457,429,106.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,511,279,097.19 |
| Accounts Receivable |
3,476,069,242.53 |
| Advances to Suppliers |
341,717,510.14 |
| Other Receivables |
124,875,576.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,237,569,205.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
97,797,008.05 |
| Total Current Assets |
19,779,198,033.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,817,283,237.45 |
| Investment Properties |
-- |
| Fixed Assetes |
16,377,401,687.77 |
| Under-construction Projects |
2,697,977,621.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,790,271,429.43 |
| R&D expenses |
-- |
| Goodwill |
94,935,452.68 |
| Long-Term Deferred and Prepaid Expenses |
8,761,689.58 |
| Deferred Income Tax Assets |
344,781,250.37 |
| Other Non-Current Assets |
214,200,791.90 |
| Sub-Total of Non-Current Assets |
32,772,286,083.75 |
| Total Assets |
52,551,484,117.19 |
| Short-Term Loans |
10,923,782,199.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
380,076,436.13 |
| Accounts Payable |
4,640,068,424.34 |
| Accounts Received In Advance |
22,794,000.00 |
| Employee Compensation Payable |
808,372,063.03 |
| Taxes Payable |
972,846,056.89 |
| Interest Payable |
-- |
| Dividend Payable |
24,500,000.00 |
| Other payables |
1,031,446,864.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
875,887,386.82 |
| Other Current Liabilities |
170,836,472.49 |
| Sub-Total of Current Liabilities |
21,281,199,646.19 |
| Long-term Loans |
1,466,049,446.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
121,137,255.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
760,601,905.02 |
| Deferred Income Tax Liabilities |
632,063,365.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,039,028,550.15 |
| Total Liabilities |
25,320,228,196.34 |
| Paid-In Capital(Or Share Stock) |
3,533,546,850.00 |
| Capital Surplus |
3,473,777,243.48 |
| Surplus Reserve |
2,726,984,742.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
14,303,841,723.74 |
| Minority Stockholder's Interest |
3,313,172,068.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,918,083,852.22 |
| Owner's Equity（Stockholder's Equity） |
27,231,255,920.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
52,551,484,117.19 |
